Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaur...
If approved, Welireg would be the only available therapy in the US for eligible ...
With continued investment and growing buzz from the industry, the AI hype is exp...
Tevogen Bio has expanded its partnership with Microsoft, aiming to further their...
The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021...
The funds will support the development of Ascentage’s pipeline, including its le...
The settlement ends the Sackler family’s ownership of the Oxycontin developer Pu...
The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Ta...
Adaptive logistics are vital for clinical trials, but there are challenges in na...
The FDA rejected the company’s initial NDA in 2021, citing the lack of an adequa...
A recent study from Dana-Farber Brigham Cancer Center has unveiled significant f...
Children born with rare genetic disorders often encounter a seemingly insurmount...
In recent advancements in the treatment of metastatic colorectal cancer (mCRC) c...
The Alliance for Clinical Trials in Oncology has recently unveiled compelling fi...
New research unveiled at the 2025 Society of Thoracic Surgeons (STS) Annual Meet...
In a groundbreaking study from the University of Cologne, researchers have unvei...
